Bob Goldman is moderating a session entitled, “Spare parts and the after-market.” Panelists will discuss the importance of replacement parts. CRA is also sponsoring the conference.
For more information on this event, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...